| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6145543 | American Journal of Obstetrics and Gynecology | 2014 | 30 Pages |
Abstract
Hyperglycemia disrupts the invasive profile of CTB by decreasing uPA and PAI-1 expression; down-regulating VEGF and PlGF; and up-regulating sEng, sFlt-1, and interleukin-6. Attenuation of CTB dysfunction by SB203580 or rosiglitazone pretreatment suggests the involvement of stress signaling.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Chase MD, MBA, Darijana BS, Dean Leonard, Steven R. MD, Richard O. MD, David C. PhD, Thomas J. PhD, Mohammad N. PhD,